Showing results (351-360 of 380) with videos related to
Sort By:
Pageof 38
Nucleic Acids Research|June 11, 1990
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspotsP M Green, A J Montandon, D R Bentley, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Polymorphism of normal factor IX detected by mouse monoclonal antibodiesA Wallmark, R Ljung, I M Nilsson, et al.Human Genetics|July 1, 1990
Two factor IX mutations in the family of an isolated haemophilia B patient: direct carrier diagnosis by amplification mismatch detection (AMD)A J Montandon, P M Green, D R Bentley, et al.European Journal of Haematology|October 1, 1991
Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosomeS Kling, A J Coffey, R Ljung, et al.European Journal of Haematology|March 1, 1989
Natural history of HIV infection in Swedish haemophiliacsE Berntorp, G Jarevi, A Wedbäck, et al.International Journal of Colorectal Disease|January 1, 1995
Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, SwedenJ Stewénius, I Adnerhill, H Anderson, et al.European Journal of Haematology|November 1, 1988
HIV-serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacsB Böttiger, M Blombäck, E Berntorp, et al.Scandinavian Journal of Infectious Diseases|January 1, 1986
Transmission of HIV infection to heterosexual partners but not to household contacts of seropositive haemophiliacsG Biberfeld, B Böttiger, E Berntorp, et al.American Journal of Epidemiology|October 29, 2000
Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 womenJ Merlo, G Berglund, E Wirfält, et al.British Journal of Haematology|July 1, 1991
Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneityP M Green, A J Montandon, R Ljung, et al.Pageof 38